Not currently recruiting at University of California Health
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Priothera SAS
- ID
- NCT05429632
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 249 study participants
- Last Updated